SCHEMBL3347587

SCHEMBL3347587

CC(=O)NCc1cc(C(N)=O)c(C)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SETDB1 Q15047 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
NNMT P40261 2/20 0.38
EPHX2 P34913 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
PPARG P37231 1/20 0.36
CD38 P28907 2/20 0.36
MAPT P10636 2/20 0.36
PTGES O14684 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
LMNA P02545 2/20 0.35
MAPK1 P28482 1/20 0.35
NLRP1 Q9C000 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3347590 0.81 SETDB1 (0.42) SETDB1L3MBTL1EPHX2NR1H4MAPT
SCHEMBL3341058 0.79 NNMT (0.39) NNMTCD38ALDH1A1POLBKMT2A
SCHEMBL3342933 0.79 POLB (0.40) NNMTCD38ALDH1A1POLBKMT2A
SCHEMBL3342943 0.76 NNMT (0.37) NNMTCD38ALDH1A1POLBKMT2A
SCHEMBL3341636 0.75 SLC6A4 (0.50) L3MBTL1NNMTMAPTALDH1A1POLB
SCHEMBL20149736 0.71 TSHR (0.50) CD38MAPTALDH1A1POLBRAB9A
SCHEMBL3343573 0.71 SLC6A2 (0.35) NNMTMAPTALDH1A1KMT2AHTT
SCHEMBL1758728 0.70 MAPT (0.46) SETDB1L3MBTL1MAPTALDH1A1POLB
SCHEMBL6529545 0.69 LMNA (0.60) SETDB1EPHX2MAPTALDH1A1RAB9A
SCHEMBL28984805 0.69 SETDB1 (0.49) SETDB1MAPTALDH1A1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393781-B1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-20100160388-A1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160388-A1 DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS P2RY1, P2RX1, P2RX3 SETDB1 3566/4885L3MBTL1 4395/4885NNMT 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.